483
InfoRLife SAInfoRLife SA – FDA 483, May 3, 2024
Record Details
InforLife SA, a sterile drug manufacturer in Campascio, Switzerland, received a Form 483 with two observations. The firm's quality control unit failed to approve or reject procedures, leading to the release of drug products with high impurity levels from packaging material. Additionally, the firm lacked adequate written procedures for production and process controls, resulting in visual inspection issues with air bubbles and cloudiness in drug products.
- Office
- Office of Partnerships
- Person
View Company Profile
ID · 74138f7e-af41-4c36-936a-247530642eeb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.